Parvovirus B19 (Human), IgG/IgM-13537
Test info
Parvovirus B19 (Human), IgG/IgM
13537
LAB13537
PARVOB19AB
Human Parvovirus B19, IgG, IgM
Differential diagnosis of acute or recent infection from past infection with human parvovirus associated with erythema infectiosum (fifth disease), aplastic crisis, and fetal infection.
Specimen
Serum
1.0 mL
0.5 mL
Immediately following collection, thoroughly mix sample by gently inverting 5 times
- Allow sample to clot for a minimum of 30 minutes
- Spin within two (2) hours of sample collection
Gold serum separator (SST) tube
- Allow sample to clot
- Spin
- Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
Ambient (preferred) - 14 days
Refrigerated - 14 days
Frozen - 14 days
Freeze/thaw cycles - stable x3
- Hemolysis
- Lipemia
- Gross bacterial contamination
Performance
LabCorp Burlington (163303): R-LC
Mo - Fr
5 days
Enzyme immunoassay (EIA)
Clinical and Interpretive info
Negative:
IgG: < 0.9 index
IgM: < 0.9 index
IgM antibodies are detectable two weeks after exposure. IgG antibody production usually occurs 18 to 24 days after exposure. The presence of IgM antibodies to parvovirus B19 provides definite evidence of recent infection.
Billing
86747 x 2
Result 5273-8
Tracking
04/10/2019
04/11/2022
04/05/2022